111 related articles for article (PubMed ID: 26497600)
1. SERPINB12 Is a Slow-Binding Inhibitor of Granzyme A and Hepsin.
Niehaus JZ; Miedel MT; Good M; Wyatt AN; Pak SC; Silverman GA; Luke CJ
Biochemistry; 2015 Nov; 54(45):6756-9. PubMed ID: 26497600
[TBL] [Abstract][Full Text] [Related]
2. SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases.
Askew YS; Pak SC; Luke CJ; Askew DJ; Cataltepe S; Mills DR; Kato H; Lehoczky J; Dewar K; Birren B; Silverman GA
J Biol Chem; 2001 Dec; 276(52):49320-30. PubMed ID: 11604408
[TBL] [Abstract][Full Text] [Related]
3. Human SERPINB12 Is an Abundant Intracellular Serpin Expressed in Most Surface and Glandular Epithelia.
Niehaus JZ; Good M; Jackson LE; Ozolek JA; Silverman GA; Luke CJ
J Histochem Cytochem; 2015 Nov; 63(11):854-65. PubMed ID: 26220980
[TBL] [Abstract][Full Text] [Related]
4. Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1.
Swanson R; Raghavendra MP; Zhang W; Froelich C; Gettins PG; Olson ST
J Biol Chem; 2007 Jan; 282(4):2305-13. PubMed ID: 17142451
[TBL] [Abstract][Full Text] [Related]
5. The Caenorhabditis elegans muscle specific serpin, SRP-3, neutralizes chymotrypsin-like serine peptidases.
Pak SC; Tsu C; Luke CJ; Askew YS; Silverman GA
Biochemistry; 2006 Apr; 45(14):4474-80. PubMed ID: 16584183
[TBL] [Abstract][Full Text] [Related]
6. Control of granzymes by serpins.
Kaiserman D; Bird PI
Cell Death Differ; 2010 Apr; 17(4):586-95. PubMed ID: 19893573
[TBL] [Abstract][Full Text] [Related]
7. Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A.
Kaiserman D; Stewart SE; Plasman K; Gevaert K; Van Damme P; Bird PI
J Biol Chem; 2014 Mar; 289(13):9408-17. PubMed ID: 24505135
[TBL] [Abstract][Full Text] [Related]
8. Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death.
de Koning PJ; Kummer JA; de Poot SA; Quadir R; Broekhuizen R; McGettrick AF; Higgins WJ; Devreese B; Worrall DM; Bovenschen N
PLoS One; 2011; 6(8):e22645. PubMed ID: 21857942
[TBL] [Abstract][Full Text] [Related]
9. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells.
Bladergroen BA; Strik MC; Wolbink AM; Wouters D; Broekhuizen R; Kummer JA; Hack CE
Eur J Immunol; 2005 Apr; 35(4):1175-83. PubMed ID: 15739160
[TBL] [Abstract][Full Text] [Related]
10. The structure of a Michaelis serpin-protease complex.
Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ
Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246
[TBL] [Abstract][Full Text] [Related]
11. Design of human granzyme B variants resistant to serpin B9.
Losasso V; Schiffer S; Barth S; Carloni P
Proteins; 2012 Nov; 80(11):2514-22. PubMed ID: 22733450
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cells.
Sipione S; Simmen KC; Lord SJ; Motyka B; Ewen C; Shostak I; Rayat GR; Dufour JM; Korbutt GS; Rajotte RV; Bleackley RC
J Immunol; 2006 Oct; 177(8):5051-8. PubMed ID: 17015688
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of a novel human Granzyme B inhibitor.
Marcet-Palacios M; Ewen C; Pittman E; Duggan B; Carmine-Simmen K; Fahlman RP; Bleackley RC
Protein Eng Des Sel; 2015 Jan; 28(1):9-17. PubMed ID: 25492933
[TBL] [Abstract][Full Text] [Related]
14. Biological activities of granzyme K are conserved in the mouse and account for residual Z-Lys-SBzl activity in granzyme A-deficient mice.
Wilharm E; Tschopp J; Jenne DE
FEBS Lett; 1999 Oct; 459(1):139-42. PubMed ID: 10508933
[TBL] [Abstract][Full Text] [Related]
15. Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A.
Tsuzuki S; Kokado Y; Satomi S; Yamasaki Y; Hirayasu H; Iwanaga T; Fushiki T
Biochem J; 2003 May; 372(Pt 1):227-33. PubMed ID: 12590650
[TBL] [Abstract][Full Text] [Related]
16. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection.
Rowshani AT; Florquin S; Bemelman F; Kummer JA; Hack CE; Ten Berge IJ
Kidney Int; 2004 Oct; 66(4):1417-22. PubMed ID: 15458434
[TBL] [Abstract][Full Text] [Related]
17. Delivery and therapeutic potential of human granzyme B.
Kurschus FC; Jenne DE
Immunol Rev; 2010 May; 235(1):159-71. PubMed ID: 20536562
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the nuclear localizing cytolytic granule serine protease granzyme B with importin alpha or beta: modulation by the serpin inhibitor PI-9.
Blink EJ; Jiansheng Z; Hu W; Calanni ST; Trapani JA; Bird PI; Jans DA
J Cell Biochem; 2005 Jun; 95(3):598-610. PubMed ID: 15791691
[TBL] [Abstract][Full Text] [Related]
19. Influence of pentoxifylline on natural cytotoxicity and expression of granzymes and PI-9, a specific granzyme B inhibitor.
Lazarczyk M; Dziunycz P; Niderla J; Milewski L; Lazarczyk MA; Boszczyk A; Samaha R; Grzela T
Int J Mol Med; 2006 Jan; 17(1):135-9. PubMed ID: 16328022
[TBL] [Abstract][Full Text] [Related]
20. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
